A novel Candida glabrata doxycycline-inducible system for in vitro/in vivo use.


Journal

FEMS yeast research
ISSN: 1567-1364
Titre abrégé: FEMS Yeast Res
Pays: England
ID NLM: 101085384

Informations de publication

Date de publication:
24 09 2022
Historique:
received: 04 07 2022
revised: 17 08 2022
accepted: 30 08 2022
pubmed: 2 9 2022
medline: 28 9 2022
entrez: 1 9 2022
Statut: ppublish

Résumé

Candida glabrata is an important pathogen causing superficial to invasive disease in human. Conditional expression systems are helpful in addressing the function of genes and especially when they can be applied to in vivo studies. Tetracycline-dependent regulation systems have been used in diverse fungi to turn-on (Tet-on) or turn-off (Tet-off) gene expression either in vitro but also in vivo in animal models. Up to now, only a Tet-off expression has been constructed for gene expression in C. glabrata. Here, we report a Tet-on gene expression system which can be used in vitro and in vivo in any C. glabrata genetic background. This system was used in a mice model of systemic infection to demonstrate that the general amino acid permease Gap1 is important for C. glabrata virulence.

Identifiants

pubmed: 36047937
pii: 6680246
doi: 10.1093/femsyr/foac046
pmc: PMC9508828
pii:
doi:

Substances chimiques

Amino Acid Transport Systems 0
Tetracycline F8VB5M810T
Doxycycline N12000U13O

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© The Author(s) 2022. Published by Oxford University Press on behalf of FEMS.

Références

Yeast. 2005 May;22(7):565-9
pubmed: 15942933
PLoS One. 2012;7(9):e45912
pubmed: 23049891
mBio. 2019 Dec 24;10(6):
pubmed: 31874914
Methods Mol Biol. 2012;813:187-93
pubmed: 22083743
FEMS Microbiol Lett. 2011 Apr;317(1):27-33
pubmed: 21204938
mSphere. 2016 Mar 02;1(2):
pubmed: 27303714
J Fungi (Basel). 2021 Oct 09;7(10):
pubmed: 34682265
ACS Synth Biol. 2015 Jul 17;4(7):842-52
pubmed: 25742460
BMC Biotechnol. 2010 Nov 24;10:81
pubmed: 21106052
J Gene Med. 2004 Jul;6(7):817-28
pubmed: 15241789
Microbiology (Reading). 1998 Sep;144 ( Pt 9):2407-2415
pubmed: 9782488
Yeast. 1997 Jul;13(9):837-48
pubmed: 9234672
Mol Biol Cell. 2011 Jun 1;22(11):1919-29
pubmed: 21471002
Methods Enzymol. 1999;306:145-53
pubmed: 10432452
Yeast. 2010 Jul;27(7):369-78
pubmed: 20148388
Can J Microbiol. 1998 Oct;44(10):965-73
pubmed: 9933915
PLoS One. 2011 Mar 09;6(3):e17589
pubmed: 21408004
J Vis Exp. 2013 Nov 26;(81):e51153
pubmed: 24300440
Curr Microbiol. 2002 Jul;45(1):37-40
pubmed: 12029525
Sci Rep. 2016 Jun 21;6:27697
pubmed: 27323850
Eur J Biochem. 1990 May 31;190(1):39-44
pubmed: 2194797
Mol Syst Biol. 2021 Jun;17(6):e10207
pubmed: 34096681
Nucleic Acids Res. 2014 Apr;42(6):e48
pubmed: 24445804
Antimicrob Agents Chemother. 2011 May;55(5):1852-60
pubmed: 21321146
Front Genome Ed. 2021 Jan 08;2:606281
pubmed: 34713231
Front Cell Dev Biol. 2022 Mar 24;10:820675
pubmed: 35399500
Nucleic Acids Res. 2005 Apr 04;33(6):e63
pubmed: 15809225
PLoS Pathog. 2014 Mar 13;10(3):e1003995
pubmed: 24626429
Proc Natl Acad Sci U S A. 2007 May 1;104(18):7628-33
pubmed: 17456602
Virulence. 2022 Dec;13(1):1285-1303
pubmed: 35795910
Proc Natl Acad Sci U S A. 2007 Jul 31;104(31):12726-31
pubmed: 17652177
BMC Genomics. 2013 Sep 14;14:623
pubmed: 24034898
Mol Ther. 2003 Feb;7(2):271-80
pubmed: 12597916
Antimicrob Agents Chemother. 2000 Sep;44(9):2411-8
pubmed: 10952588
Gene. 1989 Nov 15;83(1):57-64
pubmed: 2512199
J Fungi (Basel). 2018 Jun 05;4(2):
pubmed: 29874814
Mol Cell. 2000 Sep;6(3):723-8
pubmed: 11030351
Microbiol Mol Biol Rev. 2018 Feb 7;82(1):
pubmed: 29436478
Nucleic Acids Res. 2013 Feb 1;41(4):e57
pubmed: 23275543
FEMS Microbiol Lett. 2011 Jan;314(1):1-9
pubmed: 20846362
FEMS Yeast Res. 2015 Aug;15(5):fov042
pubmed: 26066553
Proc Natl Acad Sci U S A. 2000 Jul 5;97(14):7963-8
pubmed: 10859354
Nucleic Acids Res. 1998 Feb 15;26(4):942-7
pubmed: 9461451
Microbiology (Reading). 2000 Aug;146 ( Pt 8):1797-1814
pubmed: 10931886

Auteurs

S Schrevens (S)

Institute of Microbiology, University of Lausanne and University Hospital, Rue Bugnon 48, CH-1011 Lausanne, Switzerland.

D Sanglard (D)

Institute of Microbiology, University of Lausanne and University Hospital, Rue Bugnon 48, CH-1011 Lausanne, Switzerland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH